Mounjaro Cost With Insurance (2026)
Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research
Free comparison
Compare GLP-1 providers & cash-pay options
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Mounjaro (tirzepatide) lists ~$1,112/month. With commercial diabetes coverage and Lilly's savings card, copays often land at $25/month for eligible patients. Weight-loss indication (Zepbound) may have different formulary rules — compare in <a href="/guides/mounjaro-vs-zepbound-cost/" class="text-accent-400 underline">Mounjaro vs Zepbound</a>.
Typical insured copay
- Tier 3–4 formulary: $50–$150/mo without card
- Lilly Mounjaro Savings Card: as low as $25/mo (eligibility limits apply)
- Prior authorization required on most plans
- GLP-1 savings cards details
When insurance denies Mounjaro
Common reasons: BMI below threshold, no diabetes diagnosis, step therapy not met. See appeal guide and prior auth checklist.
Mounjaro vs other GLP-1s on your plan
Use Drug Matrix to compare Mounjaro, Zepbound, Ozempic, and Wegovy side-by-side for your state.
GLP-1 cost by state
Frequently Asked Questions
Does insurance cover Mounjaro for weight loss?
Some plans cover Mounjaro only for Type 2 diabetes; Zepbound is the weight-loss brand.